Home/Genewity/Willem-Jan Krebber, MBiotech, MSc

WK

Willem-Jan Krebber, MBiotech, MSc

Chief Development Officer

Therapeutic Areas

Rare Pediatric Diseases Immunodeficiency Genetic Disorders

Genewity Pipeline

Drug	Indication	Phase
RAG1-SCID	Recombinase 1-Activating Gene 1 Severe Combined Immunodeficiency	Clinical

Leadership Team at Genewity

Arno Bisschop, MD, PhD, MSc

Chief Executive Officer

Ir. Bart Bergstein

Chief Financial Officer

Max Renes, MPhil, MSc

Chief Business Officer

Sijmen de Vries, MD, MBA

Non-executive Board Chair

View full Genewity profile